retail news in context, analysis with attitude

Potential good news about a Covid-19 vaccine, as reported by the New York Times:

"In the worldwide race for a vaccine to stop the coronavirus, the laboratory sprinting fastest is at Oxford University.

"Most other teams have had to start with small clinical trials of a few hundred participants to demonstrate safety. But scientists at the university’s Jenner Institute had a head start on a vaccine, having proved in previous trials that similar inoculations - including one last year against an earlier coronavirus - were harmless to humans.

"That has enabled them to leap ahead and schedule tests of their new coronavirus vaccine involving more than 6,000 people by the end of next month, hoping to show not only that it is safe, but also that it works."  Early tests on monkeys suggest that it does.

"The Oxford scientists now say that with an emergency approval from regulators, the first few million doses of their vaccine could be available by September — at least several months ahead of any of the other announced efforts — if it proves to be effective," the Times writes.

KC's View:

Nice to have a little good news to report … even if this is more promise and potential.

Even if the vaccine works, we'll need a lot of it, and probably other versions because, if I understand the science correctly, this won't be a one-size-fits-all situation.

So there will need to be a lot of cooperation - on a global scale.   Not necessarily humanity's strong suit.  But maybe, in this time, we can respond to ther better angels of our nature.